Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001851044-26-000003

EVP of R&D sold 26,269 shares at $1.56 ($40,980)

From the SEC's structured data for this filing

Trades in this filing

Roberts Zachary · EVP of R&D

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-01-21 Sale : show line 1 in the form −26,269 $1.56 $40,980 616,866 D
Open-market sales · 26,269 sh · avg $1.56 · $40,980
Loading xslF345X05/wk-form4_1769202908.xml…